BioCentury
ARTICLE | Clinical News

Topofen: Phase Ib/IIa data

April 6, 2015 7:00 AM UTC

A double-blind, crossover, U.S. Phase Ib/IIa trial in 48 patients ages 18-65 that suffer recurring moderate to severe migraines, defined as 2-8 migraines per month, with or without aura showed that to...